News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|September 2, 2016

Carcinoid Tumors: What to Ask Your Oncologist

Episodes in this series

EP. 1 What Are Neuroendocrine Tumors?

EP. 1 What Are Neuroendocrine Tumors?

EP. 2 Pancreatic NETs: Michael's Story

EP. 2 Pancreatic NETs: Michael's Story

EP. 3 A Surgery Story: Pancreatic NETs

EP. 3 A Surgery Story: Pancreatic NETs

EP. 4 Why You Need an Expert in NETS

EP. 4 Why You Need an Expert in NETS

EP. 5 Living with Carcinoid Tumors

EP. 5 Living with Carcinoid Tumors

EP. 6 Brenda's Carcinoid Tumor Diagnosis

EP. 6 Brenda's Carcinoid Tumor Diagnosis

EP. 7 Why Carcinoid Tumors Might Be Missed

EP. 7 Why Carcinoid Tumors Might Be Missed

EP. 8 What a Carcinoid Cancer Diagnosis Means

EP. 8 What a Carcinoid Cancer Diagnosis Means

EP. 9 NETs: The First Steps to Treatment

EP. 9 NETs: The First Steps to Treatment

EP. 10 About The Carcinoid Cancer Foundation

EP. 10 About The Carcinoid Cancer Foundation

EP. 11 Finding Answers to Your First Questions

EP. 11 Finding Answers to Your First Questions

EP. 12 Reasons for Starting Treatment of NETs

EP. 12 Reasons for Starting Treatment of NETs

EP. 13 Pancreatic NETs: What to Ask Your Oncologist

EP. 13 Pancreatic NETs: What to Ask Your Oncologist

EP. 14 Treating Pancreatic NETs

EP. 14 Treating Pancreatic NETs

EP. 15 Carcinoid Tumors: What to Ask Your Oncologist

EP. 15 Carcinoid Tumors: What to Ask Your Oncologist

EP. 16 Approach to Treating Carcinoid Tumors

EP. 16 Approach to Treating Carcinoid Tumors

EP. 17 Patient Treatment Experiences

EP. 17 Patient Treatment Experiences

EP. 18 NETs: A Personalized Approach

EP. 18 NETs: A Personalized Approach

EP. 19 The Need for Support

EP. 19 The Need for Support

EP. 20 Affording the Best Care

EP. 20 Affording the Best Care

Newsletter

Stay up to date on cancer updates, research and education

Related Content

FDA sign image

FDA Fast Tracks FOG-001 After Early Tumor Shrinkage in Desmoid Tumors

BySpencer Feldman

November 14th 2025

Image of two men.

Breaking Down Advancements in Prostate Cancer Care

ByDr. Joshua K. Sabari,Dr. Chandler Park

November 14th 2025

Shared Loss Leads to Lifelong Friendship in Rare Cancer Caregiving

BySpencer Feldman

November 13th 2025

image of Fda.

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

November 13th 2025

Bonnie Annis

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

November 13th 2025

Trending on CURE

Breaking Down Advancements in Prostate Cancer Care

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

When One Blood Draw Could Tell More: A Look at the Cancerguard Test

Understanding That Not All Lung Cancer Cases Are Linked to Smoking

Kidney Cancer Disparities Persist Among American Indian and Alaskan Native Patients

© 2025 MJH Life Sciences^®

All rights reserved.